Congress passes extension of opioid enforcement tool
Congress has voted to temporarily extend a sweeping tool that has helped federal agents crack down on drugs chemically similar to fentanyl.
Apr 29, 2021
0
2
Congress has voted to temporarily extend a sweeping tool that has helped federal agents crack down on drugs chemically similar to fentanyl.
Apr 29, 2021
0
2
(HealthDay)—Eligible practitioners who are licensed and registered to prescribe controlled substances are now exempt from certain statutory certification requirements related to training, counseling, and other ancillary ...
Apr 29, 2021
0
1
Less than one percent of people in the United States use kratom, a plant-based substance commonly used to manage pain and opioid withdrawal, according to a study published in the American Journal of Preventive Medicine. However, ...
Apr 29, 2021
0
5
A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, ...
Apr 28, 2020
0
3
After being relegated to the fringes of legitimate scientific inquiry for nearly five decades, an increasing number of researchers, including Javier González-Maeso, Ph.D., and Mario de la Fuente Revenga, Ph.D., both in the ...
Nov 21, 2019
2
2618
The Drug Enforcement Administration was "slow to respond" as America grappled with a rising opioid epidemic, the Justice Department's inspector general said in a report Tuesday that faulted the agency for cutting back use ...
Oct 1, 2019
0
0
The Justice Department said Monday it would move forward to expand the number of marijuana growers for federally authorized cannabis research.
Aug 26, 2019
0
1
A look at how the opioid crisis grew and spread may be much clearer soon after a federal judge overseeing nearly 2,000 lawsuits filed against manufacturers, distributors and retailers of prescription painkillers ordered the ...
Jul 16, 2019
0
2
Surgical patients receiving the opioid tramadol have a somewhat higher risk of prolonged use than those receiving other common opioids, new Mayo Clinic research finds. However, the Drug Enforcement Administration (DEA) classifies ...
May 14, 2019
0
14
Two former executives of a major US pharmaceutical company were charged Tuesday with fulfilling orders they knew to be fraudulent during the opioid epidemic that has claimed tens of thousands of lives.
Apr 24, 2019
0
3